Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling

BackgroundZanthoxylum nitidum (Roxb.) DC., also named Liang Mianzhen (LMZ), one kind of Chinese herb characterized with anti-inflammatory and relieving pain potency, which is widely used to treat injuries, rheumatism, arthralgia, stomach pain and so on in China. But its mechanism related to the anti...

Full description

Bibliographic Details
Main Authors: Fenfen Qin, Han Zhang, Anlong Liu, Qisheng Wang, Qinmei Sun, Shengfeng Lu, Qian Li, Hongwei Guo, Xing Liu, Zhigang Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00359/full
_version_ 1811327976299560960
author Fenfen Qin
Fenfen Qin
Han Zhang
Han Zhang
Anlong Liu
Anlong Liu
Qisheng Wang
Qisheng Wang
Qinmei Sun
Qinmei Sun
Shengfeng Lu
Qian Li
Hongwei Guo
Xing Liu
Zhigang Lu
author_facet Fenfen Qin
Fenfen Qin
Han Zhang
Han Zhang
Anlong Liu
Anlong Liu
Qisheng Wang
Qisheng Wang
Qinmei Sun
Qinmei Sun
Shengfeng Lu
Qian Li
Hongwei Guo
Xing Liu
Zhigang Lu
author_sort Fenfen Qin
collection DOAJ
description BackgroundZanthoxylum nitidum (Roxb.) DC., also named Liang Mianzhen (LMZ), one kind of Chinese herb characterized with anti-inflammatory and relieving pain potency, which is widely used to treat injuries, rheumatism, arthralgia, stomach pain and so on in China. But its mechanism related to the anti-hyperalgesic has not been reported. The aim of this study was to investigate the analgesic activity of Liang Mianzhen on mice with Complete Freund adjuvant (CFA)-induced chronic inflammatory pain. Meanwhile, the peripheral and central mechanisms of analgesic effect of Liang Mianzhen were further examined via observing the effects of Liang Mianzhen on the signal pathway associated with inflammatory induced hyperalgesia.MethodsThe inflammatory pain model was established by intraplantar injection of CFA in C57BL/6J mice. After 1 day of CFA injection, the mice were treated with LMZ (100 mg/kg) for seven consecutive days, and the behavioral tests were measured after the daily intragastric administration of LMZ. The morphological changes on inflamed paw sections were determined by hematoxylin eosin (HE) staining. Changes in the mRNA expression levels of tumor necrosis factor (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β) and nuclear factor κB p65 (NF-κBp65) were measured on day seven after CFA injection by using real-time quantitative PCR analysis and enzyme linked immunosorbent assay (ELISA) method, respectively. Moreover, immunohistochemistry and western blotting were used to detect extracellular regulated protein kinases 1/2 (ERK1/2) and NF-κB signal pathway activation.ResultsThe extract of LMZ (100 mg/kg) showed a significant anti-inflammatory and analgesic effect in the mice model. The paw edema volume was significantly reduced after the administration of LMZ compared to CFA group, as well as the paw tissues inflammatory damage was relived and the numbers of neutrophils in mice was reduced significantly. The CFA-induced mechanical threshold and thermal hyperalgesia value were significant improved with LMZ treatment at day three to day seven. We also found the mRNA levels of TNF-α, IL-1β, IL-6 and NF-κBp65 were down-regulate after 7 days from the LMZ treatment compared to CFA group. Meanwhile, LMZ significantly suppressed over-expression of the phosphorylation of ERK1/2 and NF-κBp65 in peripheral and central.ConclusionThe present study suggests that the extract of LMZ attenuates CFA-induced inflammatory pain by suppressing the ERK1/2 and NF-κB signaling pathway at both peripheral and central level.
first_indexed 2024-04-13T15:18:18Z
format Article
id doaj.art-0dc21f0998fa452bb248d411f60e76fd
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T15:18:18Z
publishDate 2019-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-0dc21f0998fa452bb248d411f60e76fd2022-12-22T02:41:47ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-04-011010.3389/fphar.2019.00359438536Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB SignalingFenfen Qin0Fenfen Qin1Han Zhang2Han Zhang3Anlong Liu4Anlong Liu5Qisheng Wang6Qisheng Wang7Qinmei Sun8Qinmei Sun9Shengfeng Lu10Qian Li11Hongwei Guo12Xing Liu13Zhigang Lu14College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, ChinaKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, ChinaKey Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, ChinaCollege of Pharmacy, Guangxi Medical University, Nanning, ChinaCollege of Pharmacy, Shanxi University of Chinese Medicine, Taiyuan, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia, Nanjing University of Chinese Medicine, Nanjing, ChinaBackgroundZanthoxylum nitidum (Roxb.) DC., also named Liang Mianzhen (LMZ), one kind of Chinese herb characterized with anti-inflammatory and relieving pain potency, which is widely used to treat injuries, rheumatism, arthralgia, stomach pain and so on in China. But its mechanism related to the anti-hyperalgesic has not been reported. The aim of this study was to investigate the analgesic activity of Liang Mianzhen on mice with Complete Freund adjuvant (CFA)-induced chronic inflammatory pain. Meanwhile, the peripheral and central mechanisms of analgesic effect of Liang Mianzhen were further examined via observing the effects of Liang Mianzhen on the signal pathway associated with inflammatory induced hyperalgesia.MethodsThe inflammatory pain model was established by intraplantar injection of CFA in C57BL/6J mice. After 1 day of CFA injection, the mice were treated with LMZ (100 mg/kg) for seven consecutive days, and the behavioral tests were measured after the daily intragastric administration of LMZ. The morphological changes on inflamed paw sections were determined by hematoxylin eosin (HE) staining. Changes in the mRNA expression levels of tumor necrosis factor (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β) and nuclear factor κB p65 (NF-κBp65) were measured on day seven after CFA injection by using real-time quantitative PCR analysis and enzyme linked immunosorbent assay (ELISA) method, respectively. Moreover, immunohistochemistry and western blotting were used to detect extracellular regulated protein kinases 1/2 (ERK1/2) and NF-κB signal pathway activation.ResultsThe extract of LMZ (100 mg/kg) showed a significant anti-inflammatory and analgesic effect in the mice model. The paw edema volume was significantly reduced after the administration of LMZ compared to CFA group, as well as the paw tissues inflammatory damage was relived and the numbers of neutrophils in mice was reduced significantly. The CFA-induced mechanical threshold and thermal hyperalgesia value were significant improved with LMZ treatment at day three to day seven. We also found the mRNA levels of TNF-α, IL-1β, IL-6 and NF-κBp65 were down-regulate after 7 days from the LMZ treatment compared to CFA group. Meanwhile, LMZ significantly suppressed over-expression of the phosphorylation of ERK1/2 and NF-κBp65 in peripheral and central.ConclusionThe present study suggests that the extract of LMZ attenuates CFA-induced inflammatory pain by suppressing the ERK1/2 and NF-κB signaling pathway at both peripheral and central level.https://www.frontiersin.org/article/10.3389/fphar.2019.00359/fullZanthoxylum nitidumLiang Mianzheninflammatory painpro-inflammatory cytokinesNF-κBp65p-ERK1/2
spellingShingle Fenfen Qin
Fenfen Qin
Han Zhang
Han Zhang
Anlong Liu
Anlong Liu
Qisheng Wang
Qisheng Wang
Qinmei Sun
Qinmei Sun
Shengfeng Lu
Qian Li
Hongwei Guo
Xing Liu
Zhigang Lu
Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling
Frontiers in Pharmacology
Zanthoxylum nitidum
Liang Mianzhen
inflammatory pain
pro-inflammatory cytokines
NF-κBp65
p-ERK1/2
title Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling
title_full Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling
title_fullStr Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling
title_full_unstemmed Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling
title_short Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling
title_sort analgesic effect of zanthoxylum nitidum extract in inflammatory pain models through targeting of erk and nf κb signaling
topic Zanthoxylum nitidum
Liang Mianzhen
inflammatory pain
pro-inflammatory cytokines
NF-κBp65
p-ERK1/2
url https://www.frontiersin.org/article/10.3389/fphar.2019.00359/full
work_keys_str_mv AT fenfenqin analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT fenfenqin analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT hanzhang analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT hanzhang analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT anlongliu analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT anlongliu analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT qishengwang analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT qishengwang analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT qinmeisun analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT qinmeisun analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT shengfenglu analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT qianli analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT hongweiguo analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT xingliu analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling
AT zhiganglu analgesiceffectofzanthoxylumnitidumextractininflammatorypainmodelsthroughtargetingoferkandnfkbsignaling